Support program for medication treatment after jail release
Part of Mental health clinical trials.
This study tests a program that offers support and incentives to help people continue their medication for opioid use disorder after leaving jail. It aims to improve treatment engagement and reduce relapse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in jail at Clatsop County Jail.
- You are already enrolled in the jail's medication treatment program for opioid use disorder.
- You plan to keep receiving treatment from Clatsop Behavioral Healthcare after you are released.
- You speak English and can give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a system to improve care for people with opioid use disorder as they leave jail and return to the community. It aims to help patients stay in treatment and avoid interruptions.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This trial tests a peer recovery support program for people starting inpatient treatment for opioid use disorder. It aims to help you stay on medication for opioid use disorder and build a strong recovery.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This trial offers buprenorphine (a medication for opioid use disorder) to people in jail who are soon to be released. It helps you start treatment while incarcerated and continue it after you return to the community, aiming to reduce overdose and improve recovery.
This study tests if a reward-based program (called contingency management) helps people stick with their medication for opioid use disorder (like buprenorphine or methadone) after an emergency department visit.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.